Thyroid cancer in 2013: Advances in our understanding of differentiated thyroid cancer

Nature Reviews Endocrinology

Volumn 10, Issue 2, 2014, Pages 69-70

  Reiners, Christoph ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE;

AUTOPSY; CANADA; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER REGRESSION; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DEVELOPED COUNTRY; DIFFERENTIATED THYROID CANCER; DISTANT METASTASIS; DOSIMETRY; ECHOGRAPHY; ENDOCRINOLOGIST; GENOTYPE; HEALTH CARE; HUMAN; LUNG FIBROSIS; MUTATION; POPULATION; PREVALENCE; PRIORITY JOURNAL; REVIEW; SOCIAL STATUS; THYROID CARCINOMA; UNITED STATES;

CELL DIFFERENTIATION; HUMANS; INCIDENCE; IODINE RADIOISOTOPES; THYROID NEOPLASMS; TREATMENT OUTCOME;

EID: 84893021852     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2013.247     Document Type: Review

References (10)

1. Franssila, K. O. & Harach, H. R. Occult papillary carcinoma of the thyroid in children and young adults. A systemic autopsy study in Finland. Cancer 58, 715-719 (1986).
2. Udelsman, R. & Zhang, Y. The epidemic of thyroid cancer in the United States: The role of endocrinologists and ultrasounds. Thyroid http://dx.doi.org/10.1089/thy.2013.0257.
3. Li, N., Du, X. L., Reitzel, L. R., Xu, L. & Sturgis, E. M. Impact of enhanced detection on the increase in thyroid cancer incidence in the United States: Review of incidence trends by socioeconomic status within the surveillance, epidemiology, and end results registry, 1980-2008. Thyroid 23, 103-110 (2013).
4. Morris, L. G., Sikora, A. G., Tosteson, T. D. & Davies, L. The increasing incidence of thyroid cancer: The influence of access to care. Thyroid 23, 885-891 (2013).
5. Guay, B., Johnson-Obaseki, S. E., McDonald, J. T., Connell, C. & Corsten, M. Incidence of differentiated thyroid cancer by socioeconomic status and urban residence: Canada 1991-2006. Thyroid http://dx.doi.org/10.1089/thy. 2013.0308.
6. Lee, T. J., Kim, S., Cho, H. J. & Lee, J. H. The incidence of thyroid cancer is affected by the characteristics of a healthcare system. J. Korean Med. Sci. 27, 1491-1498 (2012).
7. Sabra, M. M. et al. Clinical outcomes and molecular profile of differentiated thyroid cancers with radioiodine-avid distant metastases. J. Clin. Endocrinol. Metab. 98, E829-E836 (2013).
8. Ho, A. L. et al. Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer. N. Engl. J. Med. 368, 623-632 (2013).
9. Reiners, C. et al. Twenty-five years after Chernobyl: Outcome of radioiodine treatment in children and adolescents with very high-risk radiation-induced differentiated thyroid carcinoma. J. Clin. Endocrinol. Metab. 98, 3039-3048 (2013).
10. Kim, C. et al. The risk of second cancers after diagnosis of primary thyroid cancer is elevated in thyroid microcarcinomas. Thyroid 23, 575-582 (2013).